|
Product complaint # :(b)(6).Date sent to the fda: 7/13/2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: d9, h6, h3, h4, d4.Additional h3 investigation summary: h3 investigation summary: according to the information received, needle pulled off after a few stitches.One needle and one suture piece product code f2413h were returned for analysis.Upon visual analysis of the returned sample revealed that clip off defect was observed in the strand.The barrel hole was examined under 20x magnification and revealed a remnant suture.In addition, the extreme suture was noted to be severely cut.As per returned conditions of the sample no functional test was performed.The clip off defect has been correlated to the manufacturing process classified as class 1 defect.This defect is caused by excessive pressure on the suture during swaging of the needle and consequently breaking.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.Based on the information currently available, the clip off was identified during the investigation of the sample received.This product issue will be addressed through quality system.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of post-market surveillance.A manufacturing record evaluation was performed for the finished device batch rabclt, and no non-conformances were identified.
|